TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LAB

Standard Biotools Inc

Healthcare · Medical Devices · —

0.7698$ +5.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Standard Biotools Inc (LAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 627 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LAB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
339 323 778 709 682 612 580 557 540 568 639 627
171 158 548 480 454 376 344 506 472 454 521 517
80 52 287 270 211 167 151 159 129 118 266 270
129 115 462 395 366 293 258 237 195 188 455 477
17 20 36 32 35 34 35 15 14 13 17 16
22 21 40 43 43 41 42 24 25 20 19 17
56 – – – 72 71 71 47 44 46 – –
106 106 106 106 106 111 112 – – – – –
4.3 1.4 25 24 23 29 28 – – – – –
471 160 200 198 192 141 125 132 140 143 78 87
52 109 122 124 121 66 56 98 108 108 42 57
9.0 64 60 61 61 6.2 6.3 5.1 5.1 5.5 5.5 5.6
7.3 9.2 13 13 11 12 12 7.3 6.6 5.4 8.0 9.6
60 4.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
-132 163 577 510 489 472 455 425 400 424 561 540
-981 -1,001 -1,079 -1,125 -1,152 -1,186 -1,212 -1,245 -1,280 -1,261 -1,133 -1,160
79 80 294 372 372 375 378 380 383 385 388 391

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?